Atlas Trials

Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy

Clinical trial NCT02720744 · COMPLETED

Trial details

NCT number
NCT02720744
Sponsor
Avadel
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Excessive Daytime SleepinessCataplexyNarcolepsy
Start date
2016-11-17
Primary completion
2020-03-25
Enrollment
212

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.